Risk Factors for Intrapartum Fever in Term Gestations and Associated Maternal and Neonatal Sequelae

Aim: To determine factors associated with intrapartum fever and to examine associated maternal and neonatal outcomes. Methods: Retrospective study of patients between 36(0/7) and 42(0/7) gestational weeks who entered spontaneous or induced active labor and developed temperature >= 38 degrees C; a similar group that did not develop fever were controls. Univariate and multivariate analyses were performed with p < 0.05 as significant. Results: Fifty-four febrile patients and 306 nonfebrile controls met inclusion criteria. Nulligravidity (45.8 vs. 77.8%, p < 0.001), length of first stage >= 720 min (OR 3.59, 95% CI 1.97-6.55, p < 0.001), length of second stage >= 120 min (OR 4.76, 95% CI 2.29-9.89, p < 0.001), membrane rupture >= 240 min (46.4 vs. 79.6%, p < 0.001), increasing number of vaginal exams (4 vs. 6, p < 0.001), oxytocin (44.8 vs. 63.0%, p = 0.014), and meperidine (14.7 vs. 35.2%, p < 0.001) were all associated with intrapartum fever. Associated morbidity included cesarean delivery (22.5 vs. 44.4%, p = 0.001), Apgar score <7 at 5 min (0.7 vs. 5.6%, p < 0.011), and neonatal intensive care unit admission (9.5 vs. 51.9%, p < 0.001). Conclusion: We have identified several noninfectious factors that are associated with intrapartum fever. Modification of risk factors may improve both maternal and neonatal outcomes. (C) 2017 S. Karger AG, Basel